T36.5X5
Adverse effect of aminoglycosides
Clinical Classification Guidelines
Medical Intelligence & Overview
Aminoglycosides are a class of antibiotics widely used to treat serious bacterial infections. While effective, they can sometimes cause adverse effects that may impact various parts of the body. Recognizing these potential side effects is important for appropriate medical management. The ICD-10 code T36.5X5 specifically refers to adverse effects related to the use of aminoglycosides, highlighting the importance of monitoring during treatment.
Causes & Symptoms
Clinical Causes: Extended duration of aminoglycoside therapy High doses or overdose of the medication Pre-existing kidney impairment Concurrent use of other nephrotoxic or ototoxic drugs Individual susceptibility factors, including genetic predispositions Inadequate renal function leading to drug accumulation
Key Symptoms: Signs of kidney damage, such as decreased urine output or swelling Hearing loss or ringing in the ears (tinnitus) Balance difficulties or dizziness Nausea and vomiting Muscle weakness or numbness Visual disturbances in some cases General feelings of fatigue or malaise Possible changes in blood test results indicating organ stress
Diagnostic & Treatment
Diagnosis Path: Monitoring kidney function through blood tests such as serum creatinine and blood urea nitrogen (BUN) Audiometric testing to assess hearing function if ototoxicity is suspected Assessment of neurological symptoms through physical examination Reviewing medication history and dosing schedules Imaging studies, if necessary, to evaluate any structural organ damage
Treatment Protocols: Discontinuing or reducing the dosage of aminoglycosides Providing supportive care such as hydration to support kidney function Monitoring and managing electrolyte imbalances Implementing hearing assessments and, if needed, audiologic interventions Using alternative antibiotics if infection persists Close follow-up to prevent permanent organ damage
Clinical Advice & FAQs
Billing Guidance
Is T36.5X5 a billable ICD-10 code?
Yes, T36.5X5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T36.5X5?
Clinical documentation must specify the nature of Adverse effect of aminoglycosides and any associated comorbidities for accurate reporting.
Cite this Clinical Reference